Literature DB >> 22090104

Significant association of multiple human cytomegalovirus genomic Loci with glioblastoma multiforme samples.

Padhma Ranganathan1, Paul A Clark, John S Kuo, M Shahriar Salamat, Robert F Kalejta.   

Abstract

Viruses are appreciated as etiological agents of certain human tumors, but the number of different cancer types induced or exacerbated by viral infections is unknown. Glioblastoma multiforme (GBM)/astrocytoma grade IV is a malignant and lethal brain cancer of unknown origin. Over the past decade, several studies have searched for the presence of a prominent herpesvirus, human cytomegalovirus (HCMV), in GBM samples. While some have detected HCMV DNA, RNA, and proteins in GBM tissues, others have not. Therefore, any purported association of HCMV with GBM remains controversial. In most of the previous studies, only one or a select few viral targets were analyzed. Thus, it remains unclear the extent to which the entire viral genome was present when detected. Here we report the results of a survey of GBM specimens for as many as 20 different regions of the HCMV genome. Our findings indicate that multiple HCMV loci are statistically more likely to be found in GBM samples than in other brain tumors or epileptic brain specimens and that the viral genome was more often detected in frozen samples than in paraffin-embedded archival tissue samples. Finally, our experimental results indicate that cellular genomes substantially outnumber viral genomes in HCMV-positive GBM specimens, likely indicating that only a minority of the cells found in such samples harbor viral DNA. These data argue for the association of HCMV with GBM, defining the virus as oncoaccessory. Furthermore, they imply that, were HCMV to enhance the growth or survival of a tumor (i.e., if it is oncomodulatory), it would likely do so through mechanisms distinct from classic tumor viruses that express transforming viral oncoproteins in the overwhelming majority of tumor cells.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22090104      PMCID: PMC3255835          DOI: 10.1128/JVI.06097-11

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  40 in total

Review 1.  The role of cytomegalovirus in angiogenesis.

Authors:  Patrizia Caposio; Susan L Orloff; Daniel N Streblow
Journal:  Virus Res       Date:  2010-10-01       Impact factor: 3.303

Review 2.  Viral effects on metabolism: changes in glucose and glutamine utilization during human cytomegalovirus infection.

Authors:  Yongjun Yu; Amy J Clippinger; James C Alwine
Journal:  Trends Microbiol       Date:  2011-05-12       Impact factor: 17.079

3.  HCMV-encoded chemokine receptor US28 mediates proliferative signaling through the IL-6-STAT3 axis.

Authors:  Erik Slinger; David Maussang; Andreas Schreiber; Marco Siderius; Afsar Rahbar; Alberto Fraile-Ramos; Sergio A Lira; Cecilia Söderberg-Nauclér; Martine J Smit
Journal:  Sci Signal       Date:  2010-08-03       Impact factor: 8.192

Review 4.  Why do viruses cause cancer? Highlights of the first century of human tumour virology.

Authors:  Patrick S Moore; Yuan Chang
Journal:  Nat Rev Cancer       Date:  2010-11-24       Impact factor: 60.716

5.  Isolation of cancer stem cells from adult glioblastoma multiforme.

Authors:  Xiangpeng Yuan; James Curtin; Yizhi Xiong; Gentao Liu; Sebastian Waschsmann-Hogiu; Daniel L Farkas; Keith L Black; John S Yu
Journal:  Oncogene       Date:  2004-12-16       Impact factor: 9.867

Review 6.  HCMV microinfections in inflammatory diseases and cancer.

Authors:  Cecilia Söderberg-Nauclér
Journal:  J Clin Virol       Date:  2007-12-27       Impact factor: 3.168

Review 7.  Epidemiology of brain tumors.

Authors:  Hiroko Ohgaki
Journal:  Methods Mol Biol       Date:  2009

8.  Activation of telomerase by human cytomegalovirus.

Authors:  Klas Strååt; Cheng Liu; Afsar Rahbar; Qingjun Zhu; Li Liu; Nina Wolmer-Solberg; Fenglan Lou; Zhaoxu Liu; Jie Shen; Jihui Jia; Satoru Kyo; Magnus Björkholm; Jan Sjöberg; Cecilia Söderberg-Nauclér; Dawei Xu
Journal:  J Natl Cancer Inst       Date:  2009-03-24       Impact factor: 13.506

Review 9.  Mechanisms of cytomegalovirus-accelerated vascular disease: induction of paracrine factors that promote angiogenesis and wound healing.

Authors:  D N Streblow; J Dumortier; A V Moses; S L Orloff; J A Nelson
Journal:  Curr Top Microbiol Immunol       Date:  2008       Impact factor: 4.291

10.  An integrated genomic analysis of human glioblastoma multiforme.

Authors:  D Williams Parsons; Siân Jones; Xiaosong Zhang; Jimmy Cheng-Ho Lin; Rebecca J Leary; Philipp Angenendt; Parminder Mankoo; Hannah Carter; I-Mei Siu; Gary L Gallia; Alessandro Olivi; Roger McLendon; B Ahmed Rasheed; Stephen Keir; Tatiana Nikolskaya; Yuri Nikolsky; Dana A Busam; Hanna Tekleab; Luis A Diaz; James Hartigan; Doug R Smith; Robert L Strausberg; Suely Kazue Nagahashi Marie; Sueli Mieko Oba Shinjo; Hai Yan; Gregory J Riggins; Darell D Bigner; Rachel Karchin; Nick Papadopoulos; Giovanni Parmigiani; Bert Vogelstein; Victor E Velculescu; Kenneth W Kinzler
Journal:  Science       Date:  2008-09-04       Impact factor: 47.728

View more
  77 in total

1.  Human Cytomegalovirus Induces the Expression of the AMPKa2 Subunit to Drive Glycolytic Activation and Support Productive Viral Infection.

Authors:  Diana M Dunn; Irene Rodriguez-Sanchez; Xenia Schafer; Joshua Munger
Journal:  J Virol       Date:  2020-12-02       Impact factor: 5.103

2.  Response to "Human cytomegalovirus infection in tumor cells of the nervous system is not detectable with standardized pathologico-virological diagnostics".

Authors:  Charles Cobbs
Journal:  Neuro Oncol       Date:  2014-10-13       Impact factor: 12.300

3.  Human Cytomegalovirus Productively Replicates In Vitro in Undifferentiated Oral Epithelial Cells.

Authors:  Chao Weng; Denis Lee; Christopher B Gelbmann; Nicholas Van Sciver; Dhananjay M Nawandar; Shannon C Kenney; Robert F Kalejta
Journal:  J Virol       Date:  2018-07-31       Impact factor: 5.103

4.  Profiling of microRNAs modulating cytomegalovirus infection in astrocytoma patients.

Authors:  Ravindra Pramod Deshpande; Manas Panigrahi; Chandrasekhar Y B V K; Phanithi Prakash Babu
Journal:  Neurol Sci       Date:  2018-08-08       Impact factor: 3.307

Review 5.  The impact of inflationary cytomegalovirus-specific memory T cells on anti-tumour immune responses in patients with cancer.

Authors:  Xiao-Hua Luo; Qingda Meng; Martin Rao; Zhenjiang Liu; Georgia Paraschoudi; Ernest Dodoo; Markus Maeurer
Journal:  Immunology       Date:  2018-09-10       Impact factor: 7.397

6.  RNA interference-mediated targeting of human cytomegalovirus immediate-early or early gene products inhibits viral replication with differential effects on cellular functions.

Authors:  E Xiaofei; Bradford M Stadler; Michelle Debatis; Shixia Wang; Shan Lu; Timothy F Kowalik
Journal:  J Virol       Date:  2012-03-21       Impact factor: 5.103

7.  Expression of insulin-like growth factor binding protein-2 (IGFBP-2) gene in negative and positive human cytomegalovirus glioblastoma multiforme tissues.

Authors:  Narges Ahani; Mohsen Karimi Arzenani; Reza Shirkoohi; Mohammad Rokouei; Majid Alipour Eskandani; Abbas Nikravesh
Journal:  Med Oncol       Date:  2013-12-19       Impact factor: 3.064

8.  Direct Substrate Identification with an Analog Sensitive (AS) Viral Cyclin-Dependent Kinase (v-Cdk).

Authors:  Angie C Umaña; Satoko Iwahori; Robert F Kalejta
Journal:  ACS Chem Biol       Date:  2017-12-19       Impact factor: 5.100

9.  Recognition and killing of autologous, primary glioblastoma tumor cells by human cytomegalovirus pp65-specific cytotoxic T cells.

Authors:  Smita K Nair; Gabriel De Leon; David Boczkowski; Robert Schmittling; Weihua Xie; Janet Staats; Rebecca Liu; Laura A Johnson; Kent Weinhold; Gary E Archer; John H Sampson; Duane A Mitchell
Journal:  Clin Cancer Res       Date:  2014-03-21       Impact factor: 12.531

10.  Human cytomegalovirus-encoded US28 may act as a tumor promoter in colorectal cancer.

Authors:  Zhen-Zhai Cai; Jian-Gang Xu; Yu-Hui Zhou; Ji-Hang Zheng; Ke-Zhi Lin; Shu-Zhi Zheng; Meng-Si Ye; Yun He; Chang-Bao Liu; Zhan-Xiong Xue
Journal:  World J Gastroenterol       Date:  2016-03-07       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.